DeBio Network Partners with Genomic YARSI as First Medical Partner

It’s officially on! We are very excited to announce our first medical partnership with Genomic YARSI.

DeBio Network
DeBio Network
Published in
3 min readNov 12, 2021


Image by Author

We are pleased to announce our first medical partnership with Genetics Research Centre Universitas YARSI (Genomic YARSI).

Founded in 2012, GENOMIC YARSI is based in Jakarta, Indonesia. The research center focuses on the studies of population genetics, pharmacogenomics, and genetics of infectious disease. The research is funded by various bodies, such as the Indonesian Ministry of Research, Technology and Higher Education decentralization fund, YARSI University internal funding, the National Institute of Health USA, the Genome Institute of Singapore, the Thai Ministry of Public Health, and the Japan Society for the Promotion of Science Core-to-Core Research Programs. Under the leadership of Prof. dr. Rika Yuliwulandari, Ph.D. as the head of the research center, GENOMIC YARSI has productively generated many research outputs, from scientific articles, books, databases, genetic screening kits, and patents.

In this collaboration, Genomic YARSI will genotype the NAT2 gene polymorphisms using the qPCR and Sanger Sequencing methods in DNA samples obtained from volunteers. Polymorphisms in this gene are associated with higher incidences of anti-tuberculosis drug-induced liver injury.

In other news, it has been a momentous week for DeBio Network.

DeBio Network Launch on Skyward Finance

We have officially launched our initial dex offering (IDO) on Skyward Finance. There will be 6.5 million $DBIO tokens on sale on Skyward Finance, that’s equivalent to 6.5% of the total $DBIO supply.

Skyward Finance is a fully permissionless open-source launchpad built natively on the NEAR Protocol. We decided to launch on Skyward Finance because they allow tokens to launch without any liquidity and their commitment to fairness in regards to price discovery. Prices in Skyward Finance are not determined beforehand but are determined dynamically based on market demand.

The IDO will be the next opportunity for you to invest in $DBIO. The deposit period starts on November 7th and goes until November 13th and you can deposit your $NEAR here.

$DBIO Whitelisted on Ref Finance

Our native token $DBIO has also been whitelisted by Ref Finance. You can swap $NEAR to $DBIO right after IDO. Ref Finance will also provide farming and liquidity pool (LP) bonuses for $DBIO, you can create a pool to pair $DBIO with any other token on the NEAR ecosystem, tying $DBIO closer to the ecosystem as a whole.

Image by Author

Ref Finance is the first major DeFi platform running on NEAR Protocol and has since grown rapidly with one of its liquidity pools reaching USD 1 million. Being built natively on NEAR Protocol gives Ref Finance all the benefits of a decentralized exchange on the NEAR ecosystem: low fees, fast transaction speeds, and user-friendly interoperable infrastructure are all a given.

DeBio Network Enters Booting Stage on Octopus Network

We have entered the booting stage. DeBio Network’s Appchain has already gone through most of the phases required before release on the Octopus Network. And the community has given us their immense support throughout the process.

It all began during the Voting phase when the community gave DeBio Network an astounding 400k $OCT worth of upvotes, if we adjust that to the current price of $OCT ($2.66) that is more than USD 1 million worth of votes. The community also came through during the Staging phase, DeBio Network accumulated 740k $OCT worth of validators that is almost USD 2 million votes! (USD 1.96 million to be exact).

The Octopus Network team is also giving $DBIO IDO participants a 200k $OCT worth of airdrops. For every 32.5 $DBIO you buy in their IDO sale, you get an airdrop of 1 $OCT.

So what are you waiting for? the IDO will be the next opportunity for you to invest in $DBIO. The deposit period starts on November 7th and goes until November 13th and you can deposit your $NEAR here.

The future is here, DeBio is creating solutions to revolutionize the healthcare and genetic testing industry. Are you ready to change the world with us?